My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 444

    1.

    VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.

    Deissler H, Deissler H, Lang S, Lang GE.

    Br J Ophthalmol. 2008 Jun;92(6):839-43. Epub 2008 May 29.PMID: 18511543 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Effect of VEGF165 and the VEGF aptamer pegaptanib (Macugen) on the protein composition of tight junctions in microvascular endothelial cells of the retina]

    Deissler HL, Lang GE.

    Klin Monbl Augenheilkd. 2008 Oct;225(10):863-7. Epub 2008 Oct 24. German. PMID: 18951306 [PubMed - indexed for MEDLINE]Related articles

    3.

    [In vitro studies on the mechanism of action of VEGF and its inhibitors]

    Deissler HL, Lang GE.

    Klin Monbl Augenheilkd. 2008 Jul;225(7):623-8. Review. German. PMID: 18642204 [PubMed - indexed for MEDLINE]Related articles

    4.

    Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.

    Brankin B, Campbell M, Canning P, Gardiner TA, Stitt AW.

    Exp Eye Res. 2005 Jul;81(1):22-31.PMID: 15978251 [PubMed - indexed for MEDLINE]Related articles

    5.

    Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.

    Kim JH, Kim JH, Lee YM, Ahn EM, Kim KW, Yu YS.

    J Cereb Blood Flow Metab. 2009 Sep;29(9):1559-67. Epub 2009 Jun 17.PMID: 19536074 [PubMed - indexed for MEDLINE]Related articles

    6.

    Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo.

    Lowe J, Araujo J, Yang J, Reich M, Oldendorp A, Shiu V, Quarmby V, Lowman H, Lien S, Gaudreault J, Maia M.

    Exp Eye Res. 2007 Oct;85(4):425-30. Epub 2007 Jun 13.PMID: 17714704 [PubMed - indexed for MEDLINE]Related articles

    7.

    Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.

    Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B.

    Curr Eye Res. 2006 Dec;31(12):1033-45.PMID: 17169842 [PubMed - indexed for MEDLINE]Related articles

    8.

    Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.

    Klaassen I, Hughes JM, Vogels IM, Schalkwijk CG, Van Noorden CJ, Schlingemann RO.

    Exp Eye Res. 2009 Jun 15;89(1):4-15. Epub 2009 Jan 20.PMID: 19284967 [PubMed - indexed for MEDLINE]Related articles

    9.

    Inhibition of Protein Kinase C Is not Sufficient to Prevent or Revert Effects of VEGF165 on Tight Junction Protein Claudin-1 and Permeability in Microvascular Retinal Endothelial Cells.

    Deissler HL, Deissler H, Lang GE.

    Invest Ophthalmol Vis Sci. 2009 Jul 30. [Epub ahead of print]PMID: 19643968 [PubMed - as supplied by publisher]Related articles

    10.

    Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.

    Haorah J, Heilman D, Knipe B, Chrastil J, Leibhart J, Ghorpade A, Miller DW, Persidsky Y.

    Alcohol Clin Exp Res. 2005 Jun;29(6):999-1009.PMID: 15976526 [PubMed - indexed for MEDLINE]Related articles

    11.

    Partial characterization of the human retinal endothelial cell tight and adherens junction complexes.

    Russ PK, Davidson MK, Hoffman LH, Haselton FR.

    Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2479-85.PMID: 9804158 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.

    Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, Patel J, Boyd SR, Joussen AM, Ziemssen F, Hykin PG, Moss SE.

    Cytokine. 2007 Nov;40(2):144-50. Epub 2007 Oct 23.PMID: 17959386 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.

    Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P.

    Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1837-42. Epub 2007 Mar 9.PMID: 17347807 [PubMed - indexed for MEDLINE]Related articles

    14.

    Regulation of tight junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor.

    Rodewald M, Herr D, Fraser HM, Hack G, Kreienberg R, Wulff C.

    Mol Hum Reprod. 2007 Nov;13(11):781-9.PMID: 18006538 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.

    Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA.

    Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5106-15.PMID: 17065532 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly.

    Wang W, Dentler WL, Borchardt RT.

    Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H434-40.PMID: 11123261 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells.

    Ghassemifar R, Lai CM, Rakoczy PE.

    Cell Tissue Res. 2006 Jan;323(1):117-25. Epub 2005 Sep 15.PMID: 16163490 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element.

    Felinski EA, Cox AE, Phillips BE, Antonetti DA.

    Exp Eye Res. 2008 Jun;86(6):867-78. Epub 2008 Jan 12.PMID: 18501346 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells.

    Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W.

    J Cell Physiol. 2004 Mar;198(3):359-69.PMID: 14755541 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.

    Klettner A, Roider J.

    Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4523-7. Epub 2008 Apr 25.PMID: 18441313 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity